Therapeutic effect of transplanting bone mesenchymal stem cells on the hind limbs' motor function of rats with acute spinal cord injury

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 1, 2014, Pages 262-267

  Song, Qinghua ^a   Xu, Rongmei ^a   Zhang, Quanhai ^a   Ma, Ming ^a   Zhao, Xinping ^a  

^a HENAN POLYTECHNIC UNIVERSITY   (China)

Author keywords

Mesenchymal stem cells; Repair; Spinal nerves; Transplantation

Indexed keywords

EID: 84892588805     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Zaim M, Karaman S, Cetin G, Isik S. Donor age and long-term culture affect differentiation and proliferation of human bone marrowmesenchymal stem cells. Ann Hematol 2012; 91: 1175-86.
2. Kawamoto K, Konno M, Nagano H, Nishikawa S, Tomimaru Y, Akita H, Hama N, Wada H, Kobayashi S, Eguchi H, Tanemura M, Ito T, Doki Y, Mori M, Ishii H. CD90-(Thy-1-) High Selection Enhances Reprogramming Capacity of Murine Adipose-DerivedMesenchymal Stem Cells. Dis Markers 2013; 35: 573-9.
3. Xu C. Transplantation of neural stem cells and bone marrow mesenchymal stem cells in treatment of spinal cord injury. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2012; 26: 186-9.
4. Abe K, Fujii Y, Nojima H. Evaluation of hyperalgesia in spared nerve injury model using mechanical, thermal, and chemical stimuli in the mouse. Neurol Res 2011; 33: 656-62.
5. Rahimi-Movaghar V, Jazayeri SB. When do we start Basso, Beattie, and Bresnahan assessment after experimental spinal cord injury? Acta Med Iran 2013; 51: 5183.
6. Kiskinis E, Eggan K. Progress toward the clinical application of patient-specific pluripotent stem cells. J Clin Invest 2010; 120: 51-9.
7. Anisimov SV. Cell therapy for Parkinson's disease: III. Neonatal, fetal and embryonic stem cell-based applications. Adv Gerontol 2009; 22: 296-315.
8. Park K, Eglitis MA, Mouradian MM. Protection of nigral neurons by GDNF-engineered marrow cells transplantation. Neurosci Res 2001; 40: 315-323.
9. Harvey RL, Chopp M. The therapeutic effects of cellular therapy for functional recovery after brain injury. Phys Med Rehabil Clin N Am 2003; 12: 143-151.
10. Han R, Tu LY, Yang MK, Xu T, Ma Y, Bi XJ, Sheng WB. Combined application of neural stem cell and self-assembly isoleucine-lysine-valine-alanine-valine nanofiber gel transplantation in the promotion of function recovery of spinal cord injury in rats. Zhonghua Yi Xue Za Zhi 2013; 93: 1669-73.
11. Xu Q, Zhang M, Liu J, Li W. Intrathecal transplantation of neural stem cells appears to alleviate neuropathic pain in rats through release of GDNF. Ann Clin Lab Sci 2013; 43: 154-62.
12. Solev IN, Balabanyan VY, Volchek IA, Elizarova OS, Litvinova SA, Garibova TL, Voronina TA. Involvement of BDNF and NGF in the mechanism of neuroprotective effect of human recombinant erythropoietin nanoforms. Bull Exp Biol Med 2013; 155: 242-4.
13. Yi X, Jin G, Tian M, Mao W, Qin J. Porous chitosan scaffold and ngf promote neuronal differentiation of neural stem cells in vitro. Neuro Endocrinol Lett 2011; 32: 705-10.
14. Luo Y, Zou Y, Yang L, Liu J, Liu S, Liu J, Zhou X, Zhang W, Wang T. Transplantation of NSCs with OECs alleviates neuropathic pain associated with NGF downregulation in rats following spinal cord injury. Neurosci Lett 2013; 549: 103-8.
15. Liu NB, Li H, Liu XQ. Chmnic multiple stress enhances learning and memorv capability in rats. Acta Physiol Sin 2004; 56: 615-9.
16. Schanker BD. Epigenetic regulation of brain-derived neurotrophic factor: implications in neurodevelopment and behavior. Behav Brain Sci 2012; 35: 377-8.